Evidence map›Paper›PMID 29844337›Full record

ArticleScientific reports2018

Quality control of the traditional Chinese medicine Ruyi jinhuang powder based on high-throughput sequencing and real-time PCR.

Qiang Li, Ying Sun, Huijun Guo, Feng Sang, Hongyu Ma, Hai Peng, Na Zheng, Liran Xu

Abstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Qiang LiDepartment of Acquired Immune Deficiency Syndrome Treatment and Research Center, the First Affiliated Hospital, Henan University of Chinese Medicine, Zhengzhou, 450000, China.
Ying SunGansu Institute for Drug Control, Yinan Road No. 7, Lanzhou, 730070, China.
Huijun GuoDepartment of Acquired Immune Deficiency Syndrome Treatment and Research Center, the First Affiliated Hospital, Henan University of Chinese Medicine, Zhengzhou, 450000, China.
Feng SangDepartment of Acquired Immune Deficiency Syndrome Treatment and Research Center, the First Affiliated Hospital, Henan University of Chinese Medicine, Zhengzhou, 450000, China.
Hongyu MaThermo Fisher Scientific, Building 6, No. 27, Xin Jinqiao Rd., Pudong, Shanghai, 201206, China.
Hai PengInstitute for Systems Biology, Jianghan University, Wuhan, Hubei, 430056, China.
Na ZhengThermo Fisher Scientific, Building 6, No. 27, Xin Jinqiao Rd., Pudong, Shanghai, 201206, China. na.zheng@thermofisher.com.
Liran XuDepartment of Acquired Immune Deficiency Syndrome Treatment and Research Center, the First Affiliated Hospital, Henan University of Chinese Medicine, Zhengzhou, 450000, China. hnzyyfyxlr666@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traditional Chinese medicine (TCM) has been practiced for thousands of years, although concerns about the efficacy, legality, and safety of TCM continue to be raised. Chromatographic studies have detected the presence of heavy metals and plant toxins within some TCM preparations. However, chromatography is not able to identify all of the compounds of TCM, particularly those items that are not clearly labeled on the packaging. The present study aimed to establish a supplemental method that better assesses the ingredient components of TCM preparations.We established an effective approach to screen the biological and toxical composition of TCM based on high-throughput sequencing (HTS), as well as fast detection and validation of the toxical species by real-time PCR, based on ITS2 DNA barcoding. Ruyi jinhuang powder (RHP), a classical herbal prescription containing the toxical herb Arisaematis rhizoma, was chosen to test the method. This method could determine whether the Arisaematis Rhizoma had been replaced by Pinellia pedatisecta in the RHP. The results were validated by real-time PCR. 90% compositions of RHP were identified by ITS2 DNA barcoding, suggesting that more DNA barcoding markers are needed for TCM identification. The strategy of high-throughput sequencing has the potential for comprehensive ingredient profiling for TCM preparations. Real-time PCR provides a expeditious metehod for monitoring the safety and legality of TCM preparations.

Indexed as

Medicine, Chinese TraditionalQuality ControlArisaemaChemistry Techniques, AnalyticalComplex MixturesCounterfeit DrugsDNA Barcoding, TaxonomicDrugs, Chinese HerbalHigh-Throughput Nucleotide SequencingPinelliaReal-Time Polymerase Chain ReactionComplex MixturesCounterfeit DrugsDrugs, Chinese Herbal

Identifiers

PMID29844337
PMCPMC5974330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.